| http://www.w3.org/ns/prov#value | - The application of full COLD-PCR before HRM analysis would allow identification of all types of mutations, including the minority (approximately 30%) of lung tumor TP53 mutations that retain or increase the amplicon Tm (not evaluated with the present fast COLD-PCR approach) (33).
|
